Boonsong Rawangban

  • Citations Per Year
Learn More
OBJECTIVE To evaluate the pharmacokinetics and HIV viral load response following initiation during the third trimester of pregnancy of zidovudine plus standard-dose lopinavir boosted with ritonavir (LPV/r), twice daily, until delivery for the prevention of mother-to-child transmission of HIV. DESIGN Prospective study nested within a multicenter,(More)
BACKGROUND Antiretroviral treatments decrease HIV mother-to-child transmission through pre/post exposure prophylaxis and reduction of maternal viral load. We modeled in-utero and intra-partum HIV transmissions to investigate the preventive role of various antiretroviral treatments interventions. METHODS We analysed data from 3,759 women-infant pairs(More)
There are errors in the author affiliations. The affiliations should appear as shown here: Patumrat Sripan, Sophie Le Coeur, Billy Amzal, Lily Ingsrisawang, Patrinee Traisathit, Nicole Ngo-Giang-Huong, Kenneth McIntosh, Tim R. Cressey, Suraphan Sangsawang, Boonsong Rawangban, Prateep Kanjanavikai, Jean-Marc Tréluyer, Gonzague Jourdain, Marc Lallemant and(More)
OBJECTIVES To assess the influence of body weight and missed doses on lopinavir pharmacokinetics with standard and increased doses of lopinavir/ritonavir melt extrusion tablets during late pregnancy. PATIENTS AND METHODS Lopinavir concentration data during the third trimester of pregnancy were pooled from clinical trials in Thailand (NCT00409591) and the(More)
  • 1